Health ❯ Obesity

Weight Loss

Medications Pharmaceuticals Pharmaceutical Treatments Medication Clinical Trials Bariatric Surgery GLP-1 Drugs Surgery GLP-1 Medications Treatment Options

GLP-1 Weight-Loss Draws Harsher Stigma Than Lifestyle Change, Study Finds

The authors warn this stigma can block access to evidence-based obesity treatment.

AI Review of 400,000 Reddit Posts Flags Possible GLP-1 Side Effects Beyond the Gut

Mexico Renews Warning as Counterfeit GLP-1 Weight-Loss Drugs Spread Worldwide

Zealand Plunges as Roche Obesity Drug Posts 10.7% Weight Loss With Placebo‑Like Tolerability

After Stopping GLP-1 Weight-Loss Drugs, Most Lost Weight Returns Within a Year, Analysis Finds

German Endocrinologist Calls for Statutory Coverage of Weight-Loss Injections as Illegal Procurement Rises

Restricting Two Amino Acids Triggers Beige Fat Thermogenesis in Mice

Novo’s Triple-Hormone Obesity Drug UBT251 Hits 19.7% Mean Weight Loss in China Phase 2

Private GLP-1 Weight-Loss Use in UK Skews to Middle-Class Women, Analysis Shows

GLP-1 Boom Rewrites Menus as McDonald's Tests Protein-Forward Options

Eli Lilly Builds $1.5 Billion Stockpile of Orforglipron as FDA Decision Nears

WHO-Backed Reviews Affirm GLP-1 Weight-Loss Gains as Clinicians Flag Safety and Nutrition Gaps

GLP-1 Weight-Loss Boom Triggers Safety Warnings and New Oversight

‘My 600-lb Life’ Alum Charity Pierce Dies at 50

Roche’s CT-388 Shows Up to 22.5% Placebo-Adjusted Weight Loss in Phase 2 as Phase 3 Nears

Oprah Winfrey Recasts Obesity as Disease in New Book, Backs GLP-1s as Long-Term Care

Weight Returns Quickly After Stopping GLP-1 Drugs, Oxford Review Finds

BMJ Review Finds Rapid Weight Regain After Stopping GLP-1 Weight-Loss Injections

Study Finds Weight Rebounds Within Two Years After Stopping GLP-1 Drugs

FDA Approves First Oral Wegovy Weight-Loss Pill as U.S. Availability Begins